Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas

Blood

Volumn 88, Issue 10, 1996, Pages 3919-3925

  Winter, Jane N ^a   Andersen, Janet ^b   Variakojis, Daina ^b   Gordon, Leo I ^b   Fisher, Richard I ^b   Oken, Martin M ^b   Neiman, Richard S ^b   Jiang, Shuwei ^b   Bauer, Kenneth D ^b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL FEATURE; DIPLOIDY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029830801     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3919.bloodjournal88103919     Document Type: Article

References (29)

1. Longo DL, DeVita VT Jr, Jaffe ES, Mauch P, Urba W: Lymphocytic lymphomas, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, vol 2 (ed 4). Philadelphia, PA, Lippincott, 1993, p 1859
2. Fisher RI, Hubbard SM, DeVita VT, Berard CW, Wesley R, Cossman J, Young RC: Factors predicting long-term survival in mixed, histiocytic, or undifferentiated lymphoma. Blood 58:45, 1981
3. Shipp MA, Harrington DP, Anderson JR, Armitage JO, Bonadonna G, Brittinger G, Cabanillas F, Canellos GP, Coiffier B, Connors JM, Cowan RA, Crowther D, Dahlberg S, Engelhard M, Fisher RI, Gisselbrecht C, Horning SJ, Lepage E, Lister A, Meerwaldt JH, Montserrat E, Nissen NI, Oken MM, Peterson BA, Tondini C, Velasquez WS, Yeap BY: A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987, 1993
4. Shipp MA: Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has "high-risk" disease? Blood 83:1165, 1994
5. Shackney SE, Levine AM, Fisher RI, Nichols P, Jaffe E, Schuette WH, Simon R, Smith CA, Occhipinti SI, Parker JW, Cossman J, Young RC, Lukes RJ: The biology of tumor growth in the non-Hodgkin's lymphoma. A dual parameter flow cytometry study of 220 cases. J Clin Invest 73:1201, 1984
6. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333, 1983
7. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982
8. Srigley J, Barlogie B, Butler JJ: Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry. Blood 65:1090, 1985
9. Braylan RC, Benson NA, Nourse VA: Cellular DNA of human neoplastic B-cells measured by flow cytometry. Cancer Res 44:5010, 1984
10. Bauer KD, Merkel DE, Winter JN, Marder RJ, Hauck WW, Wallmark CB, Williams TJ, Variakojis D: Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res 46:3173, 1986
11. Gordon LI, Harrington D, Andersen J, Colgan J, Glick J, Neiman R, Mann R, Resnick GD, Barcos M, Gottlieb A, O'Connell M: Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 327:1342, 1992
12. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002, 1993
13. Harlow SP, Eriksen BL, Poggensee L, Chmiel JS, Scarpelli DG, Murad T, Bauer KD: Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res 51:2403, 1991
14. Mehta CR, Patel NR, Tsiatis AA: Exact significance testing for ordered categorical data. Biometrics 40:819, 1984
15. Breiman L, Friedman JH, Olshen R, Stone CJ: Classification and Regression Trees. Belmont, CA, Wadsworth International Group, 1984
16. Therneau TM, Grambsch PM, Fleming TR: Martingale-based residuals for survival models. Biometrika 77:147, 1990
17. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L: Guidelines for implementation of clinical DNA cytometry. Cytometry 14:472, 1993
18. Bauer KD, Duque RE, Shankey TV (eds): Flow Cytometry: Principles and Applications. Baltimore, MD, Williams & Wilkins, 1993
19. Woolridge TN, Grierson HL, Weisenburger DD, Armitage JO, Sanger WG, Collins MM, Pierson JL, Pauza ME, Fordyce R, Purtilo DT: Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Res 48:6608, 1988
20. Lehtinen T, Aine R, Lehtinen M, Kallioniemi O, Leino T, Hakala T, Leinikki P, Alavaikkos M: Flow cytometric analysis of 199 histologically favourable or unfavourable non Hodgkin's lymphomas. J Pathol 157:27, 1989
21. Cowan RA, Harris M, Jones M, Crowther D: DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. Br J Cancer 60:904, 1989
22. Joensuu H, Ristamaki R, Soderstrom KO, Jalkanen S: Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma. J Clin Oncol 12:2167, 1994
23. McLaughlin P, Osborne BM, Johnston D, Jennins P, Butler JJ, Cabanillas F, Barlogie B: Nucleic acid flow cytometry in large cell lymphoma. Cancer Res 48:6614, 1988
24. Braylan RC: Lymphomas, in Bauer KD, Duque RE, Shankey TV (eds): Flow Cytometry: Principles and Applications. Baltimore, MD, Williams & Wilkins, 1993, p 203
25. Duque RE, Andreef M, Braylan RC, Diamond LW, Peiper SC: Consensus review of the clinical utililty of DNA flow cytometry in neoplastic hematopathology. Cytometry 14:492, 1993
26. 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma. Br J Cancer 66:680, 1992
27. Grogan TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangel CS, Richter LC, Miller TP: Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphoma as determined by the monoclonal antibody Ki-67. Blood 71:1157, 1988
28. Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani BN, Schnitzer B, Tubbs RR, Gaynor ER, Fisher RI: Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial. Blood 83:1460, 1994
29. Warnke RA, Strauchen JA, Burke JS, Hoppe RT, Campbell BA, Dorfman RF: Morphologic types of diffuse large cell lymphoma. Cancer 50:690, 1982